Want to join the conversation?
Brad Heffern of RBC asks about chemicals performance during 1Q16, being stronger than the macro environment. $XOM IR Jeffrey Woodbury said that chemical demand growth growing at about 1.5% above GDP sets up the investment proposition going forward. Looking across the segment, commodities have been growing strong, particularly in Europe and Asia.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?